More than a rare cause of pulmonary hypertension in the elderly
Rev Port Cardiol (Engl Ed). 2020 Mar;39(3):175-176.
doi: 10.1016/j.repc.2019.06.007.
Epub 2020 Apr 25.
[Article in
English,
Portuguese]
Affiliations
- 1 Cardiology Department, Santa Maria University Hospital (CHLN), Lisbon Academic Medical Centre, and Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Lisboa, Portugal. Electronic address: placidorui@gmail.com.
- 2 Radiology Department, Santa Maria University Hospital (CHLN), Lisbon Academic Medical Centre, Lisboa, Portugal.
- 3 Cardiology Department, Santa Maria University Hospital (CHLN), Lisbon Academic Medical Centre, and Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Lisboa, Portugal.
No abstract available
MeSH terms
-
Aged, 80 and over
-
Bosentan / administration & dosage
-
Bosentan / therapeutic use
-
Computed Tomography Angiography / methods*
-
Coronary Vessel Anomalies / diagnostic imaging
-
Drug Therapy, Combination
-
Endothelin Receptor Antagonists / administration & dosage
-
Endothelin Receptor Antagonists / therapeutic use
-
Female
-
Humans
-
Hypertension, Pulmonary / diagnosis*
-
Hypertension, Pulmonary / drug therapy
-
Hypertension, Pulmonary / etiology*
-
Phosphodiesterase 5 Inhibitors / administration & dosage
-
Phosphodiesterase 5 Inhibitors / therapeutic use
-
Pulmonary Artery / abnormalities
-
Pulmonary Artery / diagnostic imaging
-
Scimitar Syndrome / complications*
-
Scimitar Syndrome / diagnosis
-
Sildenafil Citrate / administration & dosage
-
Sildenafil Citrate / therapeutic use
-
Treatment Outcome
Substances
-
Endothelin Receptor Antagonists
-
Phosphodiesterase 5 Inhibitors
-
Sildenafil Citrate
-
Bosentan